Anstey NM - Search Results

1

Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax.

Douglas NM, Simpson JA, Phyo AP, Siswantoro H, Hasugian AR, Kenangalem E, Poespoprodjo JR, Singhasivanon P, Anstey NM, White NJ, Tjitra E, Nosten F, Price RN. Douglas NM, et al. Among authors: anstey nm. J Infect Dis. 2013 Sep 1;208(5):801-12. doi: 10.1093/infdis/jit261. Epub 2013 Jun 12. J Infect Dis. 2013. PMID: 23766527 Free PMC article.

2

Field evaluation of the ICT malaria P.f/P.v immunochromatographic test for detection of Plasmodium falciparum and Plasmodium vivax in patients with a presumptive clinical diagnosis of malaria in eastern Indonesia.

Tjitra E, Suprianto S, Dyer M, Currie BJ, Anstey NM. Tjitra E, et al. Among authors: anstey nm. J Clin Microbiol. 1999 Aug;37(8):2412-7. doi: 10.1128/JCM.37.8.2412-2417.1999. J Clin Microbiol. 1999. PMID: 10405377 Free PMC article.

3

Failure of the 'pan-malarial' antibody of the ICT Malaria P.f/P.v immunochromatographic test to detect symptomatic Plasmodium malariae infection.

Dyer ME, Tjitra E, Currie BJ, Anstey NM. Dyer ME, et al. Among authors: anstey nm. Trans R Soc Trop Med Hyg. 2000 Sep-Oct;94(5):518. doi: 10.1016/s0035-9203(00)90072-5. Trans R Soc Trop Med Hyg. 2000. PMID: 11132380 No abstract available.

4

Persistent ICT malaria P.f/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence.

Tjitra E, Suprianto S, McBroom J, Currie BJ, Anstey NM. Tjitra E, et al. Among authors: anstey nm. J Clin Microbiol. 2001 Mar;39(3):1025-31. doi: 10.1128/JCM.39.3.1025-1031.2001. J Clin Microbiol. 2001. PMID: 11230422 Free PMC article.

5

Will the high rates of post-treatment sexual stage parasitaemia seen in malaria-endemic areas make the optiMAL antigen test unreliable in predicting malaria treatment outcome?

Tjitra E, Anstey NM. Tjitra E, et al. Among authors: anstey nm. Br J Haematol. 2001 Apr;113(1):255-7. doi: 10.1046/j.1365-2141.2001.02673-2.x. Br J Haematol. 2001. PMID: 11328311 Free article. No abstract available.

6

Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia.

Tjitra E, Suprianto S, Currie BJ, Morris PS, Saunders JR, Anstey NM. Tjitra E, et al. Among authors: anstey nm. Am J Trop Med Hyg. 2001 Oct;65(4):309-17. doi: 10.4269/ajtmh.2001.65.309. Am J Trop Med Hyg. 2001. PMID: 11693875 Clinical Trial.

7

Detection of histidine rich protein 2 and panmalarial ICT Malaria Pf/Pv test antigens after chloroquine treatment of uncomplicated falciparum malaria does not reliably predict treatment outcome in eastern Indonesia.

Tjitra E, Suprianto S, Dyer ME, Currie BJ, Anstey NM. Tjitra E, et al. Among authors: anstey nm. Am J Trop Med Hyg. 2001 Nov;65(5):593-8. doi: 10.4269/ajtmh.2001.65.593. Am J Trop Med Hyg. 2001. PMID: 11716120

8

Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity.

Anstey NM, Jacups SP, Cain T, Pearson T, Ziesing PJ, Fisher DA, Currie BJ, Marks PJ, Maguire GP. Anstey NM, et al. J Infect Dis. 2002 May 1;185(9):1326-34. doi: 10.1086/339885. Epub 2002 Apr 9. J Infect Dis. 2002. PMID: 12001051

9

Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.

Tjitra E, Baker J, Suprianto S, Cheng Q, Anstey NM. Tjitra E, et al. Among authors: anstey nm. Antimicrob Agents Chemother. 2002 Dec;46(12):3947-53. doi: 10.1128/AAC.46.12.3947-3953.2002. Antimicrob Agents Chemother. 2002. PMID: 12435700 Free PMC article. Clinical Trial.

10

Higher gametocyte prevalence following failure of treatment of Plasmodium falciparum malaria with sulfadoxine-pyrimethamine and the combination of chloroquine plus sulfadoxine-pyrimethamine: implications for progression of anti-folate resistance.

Tjitra E, Suprianto S, Anstey NM. Tjitra E, et al. Among authors: anstey nm. Trans R Soc Trop Med Hyg. 2002 Jul-Aug;96(4):434-7. doi: 10.1016/s0035-9203(02)90385-8. Trans R Soc Trop Med Hyg. 2002. PMID: 12497983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters